Trial Profile
A Phase 1 Comparative Study of E2022 Current and New Patch Formulations
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2014
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 29 Jan 2014 New trial record